Impact of Diabetes on Cardiovascular Disease Risk and All-cause Mortality in Older Men: Influence of Age at Onset, Diabetes Duration, and Established and Novel Risk Factors
Overview
Affiliations
Background: We have examined the influence of age at onset and duration on the impact of diabetes mellitus on cardiovascular disease risk and all cause-mortality among men aged 60 to 79 years.
Methods: A prospective study of 4045 men aged 60 to 79 years followed up for a mean of 9 years, during which there were 372 major coronary heart disease (CHD) events (fatal and nonfatal myocardial infarction [MI]), 455 deaths from cardiovascular disease, and 1112 deaths from all causes. Men were classified as having (1) no history of MI and diabetes, (2) late-onset diabetes (diagnosed at ≥60 years or undiagnosed diabetes [fasting blood glucose level, >126.1 mg/dL]), (3) early-onset diabetes (diagnosed before age 60 years), or (4) prior MI.
Results: Men who had both MI and diabetes were excluded. Both early and late onset of diabetes were associated with a significantly increased risk of major CHD events and all-cause mortality compared with nondiabetic men who had no CHD, even after adjustment for conventional risk factors and novel risk markers (levels of C-reactive protein and von Willebrand factor and renal dysfunction). Only men with early-onset diabetes (associated with a duration of 16.7 years) showed risk similar to those with previous MI and no diabetes. The adjusted relative risks (95% confidence intervals) for major CHD events were 1.00 (reference), 1.54 (1.07-2.21), 2.39 (1.41-4.05), and 2.51 (1.88-3.36) for groups 1 through 4, respectively.
Conclusion: Both early and late onset of diabetes are associated with increased risk of major CHD events and mortality, but only early onset of diabetes (associated with >10 years' duration) appears to be a CHD equivalent.
Ribero V, Efthimiou O, Abolhassani N, Alwan H, Bauer D, Henrard S Eur J Clin Invest. 2024; 55(2):e14340.
PMID: 39465996 PMC: 11744924. DOI: 10.1111/eci.14340.
Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou N Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794138 PMC: 11124492. DOI: 10.3390/ph17050568.
Ensemble machine learning reveals key features for diabetes duration from electronic health records.
Cerono G, Chicco D PeerJ Comput Sci. 2024; 10:e1896.
PMID: 38435625 PMC: 10909161. DOI: 10.7717/peerj-cs.1896.
Gasparini D, Zuljani A, Wensveen F, Turk Wensveen T Int J Cardiol Heart Vasc. 2024; 49:101308.
PMID: 38173786 PMC: 10761307. DOI: 10.1016/j.ijcha.2023.101308.
Usman N, Winson T, Basu Roy P, Tejani V, Dhillon S, Damarlapally N Cureus. 2023; 15(10):e47294.
PMID: 38021726 PMC: 10656369. DOI: 10.7759/cureus.47294.